Prot#ISIS 766720-CS3: An Open-Label Extension Trial of IONIS GHR-LRX, an Antisense Inhibitor of the Growth Hormone Receptor administered monthly subcutaneously to Patients with Acromegaly Being Treated with Long-acting Somatostatin Receptor Ligands (SRL)"

Project: Research project

Project Details

StatusActive
Effective start/end date9/23/209/23/23

Funding

  • Medpace Clinical Research LLC (Prot#ISIS 766720-CS3)
  • Ionis Pharmaceuticals, Inc. (Prot#ISIS 766720-CS3)